Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Melatonin on Coronary Artery Calcification
NCT03966235Phase 4Unknown
- Sponsor
- Chinese PLA General Hospital
- Start
- Jun 2019
- Primary completion
- Jun 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of melatonin in Coronary artery calcification (CAC) (2 arms), sponsored by Chinese PLA General Hospital. Primary endpoint: Change in Coronary Artery Calcification Score at 6 months. Status: unknown.
02
Drugs
melatonin
03
Conditions
Coronary artery calcification (CAC)
Beyond the preview
Go deeper on NCT03966235.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03966235.